FDA Alert: Yazmin®, Yaz® and Ocella birth control pills have shown a high risk of heart attack, stroke and death – Read More
LOPEZ McHUGH LLP and its lawyers and staff are dedicated and committed to serving its existing and future clients with unprecedented excellence. We also have hit the ground running with our co-counsel and other affiliate law firms at a heightened level of devotion that has proven to bring significant success to those for and with whom we have served in the past.

Pictured from left: Marilyn Wass, Regina Johnson, Carrie Capouellez, Jim McHugh, Christina Fountain, Pauline Smith, Ramon Lopez, & Martha Borman
Learn About Our Firm’s Partners:
Ramon Rossi Lopez
James J. McHugh, Jr.
Christina Anne Fountain
View the firm’s Practice Areas
Ramon Lopez and Jim McHugh both bring to the firm significant backgrounds in extensive litigation and trial practice in the many areas of consumer rights, such as the mass tort cases listed below:
Active Pharmaceutical Litigation:
Ortho Evra Birth Control Patch®;
Ketek®;
Digitek®;
Guidant and Medtronic defibrilators and pacemakers;
Drug-eluting Heart Stents;
Vioxx®;
Plavix®;
Permax®;
Trasylol® (aprotinin);
SSRI anti-depressants causing significant heart and lung birth defects (Paxil®, Zoloft®, etc.).
Previous Pharmaceutical Litigation:
Fen-Phen, Breast Implants, Baycol®, Rezulin®, Sulzer Hips/Knees, PPA, Ephedra, Propulsid®, Zyvox®, and Zyprexa®.
Lopez McHugh continues its consumer protection watchdog activities and regularly investigates adverse events caused by many other potentially dangerous pharmaceutical drugs and medical devices.
Our lawyers have offices in California, Pennsylvania, and New Jersey. With our involvement in mass tort and class action litigation, we are affiliated with attorneys in many states and handle lawsuits concerning dangerous drugs, defective medical devices, car accidents, medical malpractice, nursing home abuse, and much more. If you or someone you know has been injured due to the negligence of others, contact us for a free consultation.